Health
Take-at-home COVID drug molnupiravir may be on its way — but vaccination is still our first line of defence – The Conversation AU
Merck announced preliminary data suggesting the drug reduced the risk of hospitalisation and death by 50%.
The Australian government has pre-purchased 300,000 courses of an experimental antiviral oral drug called molnupiravir.
Interim results announced by the company, US pharmaceutical Merck, show the drug halved the number of patients who ended up in hospital…
Continue Reading
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General11 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals